International journal of molecular sciences
July 11, 2025
Sofia Sakopoulos, Mcwelling Todman
6 citations
Ketamine infusion therapy produces rapid antidepressant effects in people with treatment-resistant depression, and combining it with weekly psychotherapy yields the strongest symptom reduction. A retrospective chart review of patients receiving single or repeated ketamine infusions, with or without concurrent psychotherapy, measured depression severity using Beck Depression Inventory scores before treatment and 30 days after. All groups showed significant symptom improvement, but those who also attended weekly psychotherapy experienced the most pronounced effects. The number of infusions did not significantly change outcomes. The findings suggest that integrating psychotherapy with ketamine treatment enhances therapeutic response, possibly by taking advantage of ketamine-induced neural plasticity.
Progress in neuro-psychopharmacology & biological psychiatry
April 2, 2025
C J Healy, Aaron Frazier, Stephen Kirsch et al.
6 citations
Adults with histories of childhood maltreatment who used psychedelic drugs with therapeutic intent at ceremonies or raves showed significant improvements in PTSD symptoms, complex PTSD symptoms, trait shame, social connectedness, and general connectedness from before the experience to two months afterward. The size of these improvements was large. Changes in these outcomes were linked to specific aspects of the acute psychedelic experience, such as subjective effects. The findings suggest that the social and psychological context of group psychedelic use may contribute to lasting mental health benefits for this population.
July 26, 2024
C. J. Healy, Aaron Frazier, Stephen Kirsch et al.
5 citations
preprint
Adults with childhood maltreatment histories who used psychedelic drugs with therapeutic intent at ceremonies or raves showed significant improvements in PTSD symptoms, complex PTSD symptoms, trait shame, social connectedness, and general connectedness from before the experience to two months afterward, with effect sizes ranging from 0.73 to 1.12. The degree of improvement was linked to specific acute subjective effects of the psychedelic experience, suggesting that the psychosocial context of these group settings may contribute to therapeutic benefits.